Literature DB >> 11273642

Brn-3a activates the expression of Bcl-x(L) and promotes neuronal survival in vivo as well as in vitro.

M D Smith1, L A Melton, E A Ensor, G Packham, P Anderson, R A Kinloch, D S Latchman.   

Abstract

The determination of cell fate plays a critical role during the later stages of embryogenesis and the early postnatal period-a time during which approximately half of neurons born during neurogenesis undergo programmed cell death. It has previously been reported that the type IV POU domain transcription factor Brn-3a plays a role in the maturation and survival of sensory neuronal populations. Indeed we have shown that the long form of Brn-3a is capable of activating expression of the antiapoptotic Bcl-2 gene and enhancing neuronal survival in cultures of sensory neurons. In this study, we report the identification of another antiapoptotic family member, Bcl-x(L), as a target gene of Brn-3a in sensory neurons, providing a further mechanism by which Brn-3a determines sensory neuronal fate during development. Bcl-x(L) gene expression is activated by Brn-3a in sensory but not in sympathetic neurons and its expression is reduced by antisense inhibition of Brn-3a expression in sensory neurons. Most importantly, both Bcl-x(L) expression and neuronal survival are enhanced by the overexpression of Brn-3a in dorsal root ganglion in vivo in a model of sciatic nerve injury in the intact animal. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11273642     DOI: 10.1006/mcne.2000.0927

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  11 in total

1.  A minimal Bcl-x promoter is activated by Brn-3a and repressed by p53.

Authors:  K L Sugars; V Budhram-Mahadeo; G Packham; D S Latchman
Journal:  Nucleic Acids Res       Date:  2001-11-15       Impact factor: 16.971

2.  Distinct promoter elements mediate the co-operative effect of Brn-3a and p53 on the p21 promoter and their antagonism on the Bax promoter.

Authors:  C Perez-Sanchez; V S Budhram-Mahadeo; D S Latchman
Journal:  Nucleic Acids Res       Date:  2002-11-15       Impact factor: 16.971

3.  Axotomy-induced early down-regulation of POU-IV class transcription factors Brn-3a and Brn-3b in retinal ganglion cells.

Authors:  Jochen H Weishaupt; Nikolaj Klöcker; Mathias Bähr
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

4.  A simple technique for the prediction of interacting proteins reveals a direct Brn-3a-androgen receptor interaction.

Authors:  Daniel C Berwick; James K J Diss; Vishwanie S Budhram-Mahadeo; David S Latchman
Journal:  J Biol Chem       Date:  2010-03-12       Impact factor: 5.157

5.  Whole number, distribution and co-expression of brn3 transcription factors in retinal ganglion cells of adult albino and pigmented rats.

Authors:  Francisco M Nadal-Nicolás; Manuel Jiménez-López; Manuel Salinas-Navarro; Paloma Sobrado-Calvo; Juan J Alburquerque-Béjar; Manuel Vidal-Sanz; Marta Agudo-Barriuso
Journal:  PLoS One       Date:  2012-11-16       Impact factor: 3.240

6.  Interaction of Brn3a and HIPK2 mediates transcriptional repression of sensory neuron survival.

Authors:  Amanda K Wiggins; Guangwei Wei; Epaminondas Doxakis; Connie Wong; Amy A Tang; Keling Zang; Esther J Luo; Rachael L Neve; Louis F Reichardt; Eric J Huang
Journal:  J Cell Biol       Date:  2004-10-18       Impact factor: 10.539

7.  Essential but partially redundant roles for POU4F1/Brn-3a and POU4F2/Brn-3b transcription factors in the developing heart.

Authors:  Lauren J Maskell; Kashif Qamar; Aram A Babakr; Thomas A Hawkins; Richard J Heads; Vishwanie S Budhram-Mahadeo
Journal:  Cell Death Dis       Date:  2017-06-08       Impact factor: 8.469

8.  Ewing sarcoma protein ewsr1 maintains mitotic integrity and proneural cell survival in the zebrafish embryo.

Authors:  Mizuki Azuma; Lisa J Embree; Hatem Sabaawy; Dennis D Hickstein
Journal:  PLoS One       Date:  2007-10-03       Impact factor: 3.240

9.  The neural crest transcription factor Brn3a is expressed in melanoma and required for cell cycle progression and survival.

Authors:  Tobias Hohenauer; Carola Berking; Andreas Schmidt; Sebastian Haferkamp; Daniela Senft; Claudia Kammerbauer; Sabine Fraschka; Saskia Anna Graf; Martin Irmler; Johannes Beckers; Michael Flaig; Achim Aigner; Sabrina Höbel; Franziska Hoffmann; Heiko Hermeking; Simon Rothenfusser; Stefan Endres; Thomas Ruzicka; Robert Besch
Journal:  EMBO Mol Med       Date:  2013-05-13       Impact factor: 12.137

10.  POU4F1 promotes the resistance of melanoma to BRAF inhibitors through MEK/ERK pathway activation and MITF up-regulation.

Authors:  Lin Liu; Qiao Yue; Jingjing Ma; Yu Liu; Tao Zhao; Weinan Guo; Guannan Zhu; Sen Guo; Shiyu Wang; Tianwen Gao; Chunying Li; Qiong Shi
Journal:  Cell Death Dis       Date:  2020-06-12       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.